Cronos Group Inc.: Cronos Group Reports 2023 First Quarter R

Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022; on a constant

Related Keywords

Ukraine , Canada , Israel , Russia , Toronto , Ontario , United States , Canadian , Israeli , Mike Gorenstein , Cronos Growco , Shayne Laidlaw , Drug Administration , Ontario Securities Commission Settlement Agreement , Ginkgo Bioworks Holdings Inc , Company The Altria Investment , Cronos Growing Company Inc , Altria Group Inc , Us Federal Trade Commission , Nasdaq , Bloomberg , Trademark Office , Cronos Group , Us Department Of Agriculture , Us Drug Enforcement Administration , Cronos Group Inc , Pharmacann Option In Inc , Israeli Shekel , Kiwi Haze , Deep Dreamz , Sonic Lemon Fuel , Growing Company , Forward Looking Statements , Looking Statements , Peace Naturals Campus , Ginkgo Bioworks Holdings , Enforcement Administration , Trade Commission , Altria Group , Ontario Securities Commission , Settlement Order , Settlement Agreement , Securities Act , Pharmacann Option , Altria Investment , Annual Report , Improvement Act , Consolidated Statements , Net Loss , Generally Accepted Accounting Principles , Months Ended March , Peace Naturals , Israeli New Shekels , Gefallene Big Techs , Cronos , Group , Reports , 023 , First , Quarter , Results ,